SCHEMBL6463980

SCHEMBL6463980

NC(=O)CC[C@H](CCc1ccccc1)C(O)c1nc2cc(C(F)(F)F)ccc2o1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 1/20 0.38
PIM2 Q9P1W9 1/20 0.38
AKR1B1 P15121 1/20 0.38
PPARG P37231 1/20 0.37
PPARD Q03181 1/20 0.37
PPARA Q07869 1/20 0.37
DAGLA Q9Y4D2 1/20 0.37
PTPN2 P17706 3/20 0.36
PTPN1 P18031 3/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
KDM4E B2RXH2 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
MAPT P10636 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
HSD17B10 Q99714 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6466099 0.82 DAGLA (0.53) DAGLANPC1RAB9AKDM4ECYP1A2
SCHEMBL6466216 0.80 DAGLA (0.44) PIM1PIM2AKR1B1PPARGPPARD
SCHEMBL7186564 0.74 MMP1 (0.39) NPC1RAB9A
SCHEMBL6463984 0.73 DAGLA (0.40) PIM1PIM2AKR1B1PPARGPPARD
SCHEMBL7730692 0.73 CTSL (0.42) DAGLAPTPN2PTPN1NPC1RAB9A
SCHEMBL6466221 0.72 DAGLA (0.41) PIM1PIM2AKR1B1PPARGPPARD
SCHEMBL6466213 0.72 CTSL (0.45) PIM1PIM2AKR1B1PPARGPPARD
SCHEMBL6207598 0.67 HDAC3 (0.50) DAGLANPC1RAB9AMAPTSMN1; SMN2
SCHEMBL5703678 0.67 HDAC3 (0.50) DAGLANPC1RAB9AMAPTSMN1; SMN2
SCHEMBL7732434 0.67 CTSL (0.43) NPC1RAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1516877-A1 Amine derivatives as protease inhibitors AXYS PHARMACEUTICALS, INC. (US) 2005-03-23 EP disclosed